In most European countries drug prices are negotiated at scale, because of public institution negotiating directly with pharmaceutical companies (most expensive

In most European countries drug prices are negotiated at scale, because of public institution negotiating directly with pharmaceutical companies (most expensive drugs are the ones in international shortage, e.g. hepatitis C drugs, etc.). So what happens in the US is that pharmaceutical companies apply the "divide an conquer" rule, having a de facto monopoly.